文献速递结核与非结核分枝杆菌

越南肺结核患者治疗后死亡率的前瞻性队列研究

Post-treatment Mortality Among Patients With Tuberculosis: A Prospective Cohort Study of 10 964 Patients in Vietnam.
PubMed 文献 · Clin Infect Dis · 2019-01-01

该研究在越南70家诊所纳入10964例涂阳肺结核患者及25707名家庭对照,随访至少2年,比较年龄性别校正后的累积死亡率。患者中位随访2.9年死亡9%,其中治疗期3.1%、出院后5.8%,标准化死亡比为4.0(95%CI 3.7-4.2),44.7%死者可能死于结核。

要点

  • 肺结核患者死亡风险显著升高,标准化死亡比4.0(95%CI 3.7-4.2)。
  • 出院后死亡占多数(5.8%),需关注治疗后随访。
  • 降低结核死亡需早期发现耐药、提高疗效并管理非传染性疾病。

核心结论

  • 接受治疗的肺结核患者死亡风险显著升高,尤其是治疗后时期。

研究设计与样本

  • 前瞻性队列研究,在越南70家诊所纳入10964例成人涂阳肺结核患者,并以25707名同户人群为对照。
  • 患者接受8个月标准化方案,随访至少2年,通过访谈确认生存、链接登记处判断复发并行口头尸检。

主要发现

  • 患者中位随访2.9年期间9%死亡:治疗期342例(3.1%),出院后637例(5.8%)。
  • 与对照人群相比,年龄性别校正后标准化死亡比为4.0(95%CI 3.7-4.2)。
  • 44.7%的死亡患者可能死于结核。

临床怎么用

  • 对肺结核患者应重视出院后随访和死亡风险评估。
  • 降低结核死亡需加强耐药早期检测、提高治疗有效性并管理非传染性疾病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tuberculosis is the leading infectious cause of death. Steep reductions in tuberculosis-related mortality are required to realize the World Health Organization's "End Tuberculosis Strategy." However, accurate mortality estimates are lacking in many countries, particularly following discharge from care. This study aimed to establish the mortality rate among patients with pulmonary tuberculosis in Vietnam and to quantify the excess mortality in this population. METHODS: We conducted a prospective cohort study among adult patients treated for smear-positive pulmonary tuberculosis in 70 clinics across Vietnam. People living in the same households were recruited as controls. Participants were re-interviewed and their survival was established at least 2 years after their treatment with an 8-month standardized regimen. The presence of relapse was established by linking identifying data on patients and controls to clinic registries. Verbal autopsies were performed. The cumulative mortality among patients was compared to that among a control population, adjusting for age and gender. RESULTS: We enrolled 10964 patients and 25707 household controls. Among enrolled tuberculosis patients, 9% of patients died within a median follow-up period of 2.9 years: 342 (3.1%) during treatment and 637 (5.8%) after discharge. The standardized mortality ratio was 4.0 (95% confidence interval 3.7-4.2) among patients with tuberculosis, compared to the control population. Tuberculosis was the likely cause of death for 44.7% of these deceased patients. CONCLUSIONS: Patients treated for tuberculosis had a markedly elevated risk of death, particularly in the post-treatment period. Interventions to reduce tuberculosis mortality must enhance the early detection of drug-resistance, improve treatment effectiveness, and address non-communicable diseases.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Fox GJ, Nguyen VN, Dinh NS, et al. Post-treatment Mortality Among Patients With Tuberculosis: A Prospective Cohort Study of 10 964 Patients in Vietnam. Clin Infect Dis. 2019. PMID: 30202910. doi:10.1093/cid/ciy665

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。